CRUSE Control Urticaria vs CRF.one
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CRUSE Control Urticaria
This app helps individuals manage chronic urticaria by tracking daily symptoms and their impact on quality of life. It facilitates communication with healthcare providers to optimize treatment based on recorded data. Developed by leading dermatologists and allergologists, it aims to provide better control over the condition.
- Daily symptom recording
- Quality of life impact tracking
- Treatment response monitoring
- Physician collaboration tool
- Developed by medical experts
Read full descriptionHide full description
CRUSE® is an APP developed by renowned dermatologists and allergoligists to help patients with Chronic Urticaria manage their condition. Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day. Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician. Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you. Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres. Are you a physician? Find out more on www.cruse-control-com
CRF.one
Read full descriptionHide full description
CRF.one is a secure and intuitive mobile application designed for real-world clinical research, registries, and observational studies. The app complements the CRF.one web platform and enables clinicians, study staff, and participants to collect and manage clinical data directly on their mobile devices — even in offline mode. CRF.one supports a wide range of study types, including multicenter registries, longitudinal follow-up projects, and patient-reported outcome (PRO) studies. With a modern user interface and robust data protection features, the app ensures high-quality data collection in compliance with Good Clinical Practice (GCP) and international privacy standards. CRF.one is developed by Swiss4ward, a company with over 15 years of experience in dermatology research platforms and clinical registry software. The app is used by hospitals, research centers, and academic groups across Europe. Whether you conduct clinical research, manage a registry, or participate in a study, CRF.one provides a reliable, modern, and secure tool for mobile data collection.
Screenshots
Verdict
The clearest difference is update cadence: CRUSE Control Urticaria at weekly against CRF.one's fortnightly. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ad data · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
CRUSE Control Urticaria ships an update weekly, CRF.one fortnightly. The most recent releases landed on November 14, 2026 and November 20, 2026 respectively.
| Parameter | CRUSE Control Urticaria | CRF.one |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (8 ratings) — better | — |
| Positive reviews | 75.9% of reviews | — |
| Number of ratings | 8 — better | — |
| Update frequency | Weekly — better | Fortnightly |
| Ad data | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 15.5 — better | 15.6 |
| Further details — not scored | ||
| Size | 35 MB | 28 MB |
| Age rating | 17+ | 4+ |
| Developer | Moxie GmbH | swiss4ward Europe S.L. |
In-app purchases
CRUSE Control Urticaria
No in-app purchases
CRF.one
No in-app purchases







